China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Study on Efficacy, Compliance and Safety of Fexofenadine Hydrochloride Dry Suspension Combined with Basic Therapy in Children with Chronic Allergic Rhinitis Complicated with Asthma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131268

Registration Time: 2026/08/31

Type: Interventional study

Primary Sponsor: Qilu Hospital of Shandong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332526

Published by HT Digital Content Services with permission from Health Daily Digest....